ArticleCells2022

S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus.

Christoph Treese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.